BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29713019)

  • 1. Imaging of angiogenesis of human umbilical vein endothelial cells by uptake of exosomes secreted from hepatocellular carcinoma cells.
    Yukawa H; Suzuki K; Aoki K; Arimoto T; Yasui T; Kaji N; Ishikawa T; Ochiya T; Baba Y
    Sci Rep; 2018 Apr; 8(1):6765. PubMed ID: 29713019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R; Wang Y; Zhang X; Feng M; Ma J; Li J; Yang X; Fang F; Xia Q; Zhang Z; Shang M; Jiang S
    Mol Cancer; 2019 Jan; 18(1):18. PubMed ID: 30704479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.
    Zhao S; Li J; Zhang G; Wang Q; Wu C; Zhang Q; Wang H; Sun P; Xiang R; Yang S
    Cell Physiol Biochem; 2019; 53(1):19-35. PubMed ID: 31162914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
    Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
    Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
    Matsuura Y; Wada H; Eguchi H; Gotoh K; Kobayashi S; Kinoshita M; Kubo M; Hayashi K; Iwagami Y; Yamada D; Asaoka T; Noda T; Kawamoto K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Dig Dis Sci; 2019 Mar; 64(3):792-802. PubMed ID: 30465177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway.
    Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC
    Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties.
    Wang S; Xu M; Li X; Su X; Xiao X; Keating A; Zhao RC
    J Hematol Oncol; 2018 Jun; 11(1):82. PubMed ID: 29898759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
    J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-derived GTF2H2 from Huh7 cells can inhibit endothelial cell viability, migration, tube formation, and permeability.
    Li Z; Li Y; Ouyang Q; Li X; Huang J
    Tissue Cell; 2022 Dec; 79():101922. PubMed ID: 36116407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis.
    Wang F; Fei H; Qi B; Yao S; Chang Z
    Mol Cell Biochem; 2012 May; 364(1-2):165-71. PubMed ID: 22209835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
    Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
    Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
    Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
    Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.
    Wu YY; Chen L; Wang GL; Zhang YX; Zhou JM; He S; Qin J; Zhu YY
    J Mol Histol; 2013 Aug; 44(4):433-45. PubMed ID: 23636606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma.
    Xie JY; Wei JX; Lv LH; Han QF; Yang WB; Li GL; Wang PX; Wu SB; Duan JX; Zhuo WF; Liu PQ; Min J
    Cell Commun Signal; 2020 Mar; 18(1):46. PubMed ID: 32183816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
    Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX
    Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.